Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Kellett, R. Niven (Warrington, United Kingdom). Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 4587

Member's Comments

No comment yet.

Related content which might interest you: Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma Source: Eur Respir J 2011; 37: 342 Year: 2011 Airway surface pH in subjects with cystic fibrosis Source: Eur Respir J 2003; 21: 37-42 Year: 2003 RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 The assesment of aerosol solution lung deposition in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 584s Year: 2004 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Different hypertonic sodium chloride solution influence on external respiratory function in chronic obstructive lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 181s Year: 2002 Inhaled mannitol as treatment for children with cystic fibrosis Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease Year: 2008 Comparative evaluation of mucociliary clearance in patients with mucoviscedosis and chronic obstructive bronchitis and one influence of hypertonic sodium chloride concentrations on it Source: Eur Respir J 2001; 18: Suppl. 33, 124s Year: 2001 Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis Source: Eur Respir J 2002; 19: 294-302 Year: 2002 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004 Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Source: Eur Respir J 2012; 40: 61-66 Year: 2012 Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 450s Year: 2007 Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway Source: Eur Respir J 2010; 35: 781-786 Year: 2010 Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018 Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis Source: Eur Respir J 2008; 31: 765-772 Year: 2008 Optimising inhaled mannitol for cystic fibrosis in an adult population Source: Breathe 2015; 11:39-48 Year: 2015